Cryptococcus gattii meningitis: Observation in a Spanish patient;Meningitis por Cryptococcus gattii: Descripción de un caso autóctono en España

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 6, 2008, Pages 395-396

  Solla, Itziar ^a   Morano, Luis Enrique ^a   Vasallo, Francisco ^a   Cuenca Estrella, Manuel ^b  

^a UNIVERSITY OF VIGO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MANNITOL; VORICONAZOLE;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCUS; HUMAN; LETTER; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RURAL AREA; SPAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; URUGUAY;

EID: 45849090290     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13123846     Document Type: Article

References (14)

1. Kwon-Chung K, Boekhout T, Fell J, Díaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon. 2002;51:804-6.
2. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol. 1990;28:1642-4.
3. Pfeiffer TJ, Ellis DH. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J Med Vet Mycol. 1992;30:407-8.
4. Baro T, Torres-Rodríguez JM, De Mendoza MH, Morera Y, Alia C. First identification of autochthonous Cryptococcus neoformans var. gattii isloated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol. 1998;36:458-61.
5. Colom MF, Frases S, Ferrer C, Jover A, Andreu M, Reus S, et al. First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol. 2005;43:3548-50.
6. Rodríguez-Tudela JL, Díaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005;49:4026-34.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A2. Wayne: NCCLS, 2002.
8. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett K, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A. 2004;101:17258-63.
9. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol. 2004;53:935-40.
10. Chen YC, Chang SC, Shih CC, Hung C, Luhbd K, Luhbd Y, et al. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis. 2000;36:175-83.
11. Trilles L, Fernandez-Torres B, Lazera Mdos S, Wanke B, Guarro J. In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol. 2004;42:4815-7.
12. Fernandes O, Pasos X, Souza L, Miranda A, Cerqueira C, Silva M. In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil. Mem Inst Oswaldo Cruz. 2003;98:839-41.
13. Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, Iqbal N, et al. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis. 2006;43:1077-80.
14. Tay S, Haryanty T, Ng K, Rohani M, Hamimah H. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Mycoses. 2006;49:324-30.